Clinical Trial Update: Clinical Trial in Patients Diagnosed With Immune Thrombocytopenic Purpura [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial in immune thrombocytopenia completed, with results posted in February 2016; sponsor was Instituto Grifols.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Snippet

Sponsor: Instituto Grifols, S.A. | Conditions: Immune (Idiopathic) Thrombocytopenic Purpura | Phase 3 | Status: COMPLETED | Results posted: 2016-02-08